GSA Capital Partners’s Kronos Bio KRON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-57,347
Closed -$75K 1854
2024
Q1
$75K Buy
57,347
+32,201
+128% +$36.7K 0.01% 1511
2023
Q4
$31K Sell
25,146
-29,375
-54% -$32.5K ﹤0.01% 1430
2023
Q3
$71K Sell
54,521
-231,644
-81% -$374K 0.01% 1402
2023
Q2
$492K Sell
286,165
-120,197
-30% -$191K 0.05% 750
2023
Q1
$593K Sell
406,362
-33,564
-8% -$64.3K 0.06% 604
2022
Q4
$713K Buy
439,926
+286,235
+186% +$659K 0.09% 389
2022
Q3
$515K Buy
153,691
+66,845
+77% +$302K 0.07% 547
2022
Q2
$316K Buy
86,846
+43,284
+99% +$196K 0.05% 790
2022
Q1
$315K Buy
+43,562
New +$371K 0.04% 859

Other funds holding KRON